IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-03-26 (consalud.es)
Investment in biopharmaceutical R&D increases 2,874 million euros in a single year
A new IQVIA report on research in the biopharmaceutical sector includes a remarkable increase in investment but a 17% decrease in the start of clinical trials since 2021, returning to prepaandemics levels
Read more
2025-03-18 (hitnews.co.kr)
180 billion Denosumab Market, 'Hanmi VS Chong Kun Dang vs. Daewoong'
Another union front that participates in the competition for the prescription market of 'Prolia (ingredient Denosumab)', which is a treatment for osteoporosis, is Samsung Bioepis and Hanmi Pharm, and Amgen's original prolia is Chong Kun Dang and Celltrion's Storoclo is sold by Daewoong Pharmaceuticals. Sales will be a point of watching, and Samsung Bioepis (CEO Kyung -Ah Kim) and Hanmi Pharm (CEO Jae -Hyun Park) will launch the domestic launch of osteoporosis treatment prolia biosimilar (project name SB16, ingredient name Denosumab) at Hanmi Pharmaceutical Headquarters Park Hall on the 18th.
Read more
2024-01-15 (startupper.gr)
ATHINA: Implementation of an innovative European program to upgrade pandemic prevention begins
Everything about the Greek Startup Scene
Read more
2023-11-16 (jaimelesstartups.fr)
The IQVIA accelerator presents the 10 startups in its class!
IQVIA closes the 2023 edition of its Accelerator Program, in collaboration with European health start-ups
Read more
2023-09-12 (pharma-relations.de)
IQVIA: Startups network in the pan-European accelerator program
A cross-country kick-off event for IQVIA's Accelertor program will take place during IQVIA's annual meeting on September 27, 2023. The program connects international startups in the healthcare sector with the industry. Whether individual pilot projects or a potential collaboration – the
Read more
2019-11-27 (newsobserver.com)
Clinical research company plans 749-job expansion in Durham after landing incentives
Q2 Solutions will add the jobs in two separate phases over the next eight years.
Read more
(businesswire.com)
IQVIA Laboratories launches Site Lab Navigator with breakthrough e -Requisition innovation to transform clinical trials
IQVIA Laboratories, a leading global drug discovery and development laboratory services organization, announces the launch of Site Lab Navigator, an a
Read more